215 results
Page 8 of 11
8-K
EX-99.1
ltdo95c 05
25 Oct 19
VBI Vaccines to Present New Immuno-Oncology Data at the World Vaccine Congress Europe 2019
12:00am
8-K
EX-99.1
rmlm8sztqj26g6d100
23 Oct 19
VBI Vaccines Announces Late-Breaker Poster Presentation at The Liver Meeting® 2019
6:05am
8-K
7cu5 kgj0rz
2 Oct 19
Other Events
9:00am
8-K
EX-99.1
99i 3bu8i
2 Oct 19
Other Events
9:00am
424B5
bur8de603jekqmb
20 Sep 19
Prospectus supplement for primary offering
5:28pm
8-K
EX-1.1
y6bhqferq
20 Sep 19
VBI Vaccines Announces Proposed Public Offering of Common Shares
5:27pm
424B5
awx2xoiz4q9e7nws6qe
18 Sep 19
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.1
3sw 1rzfopxsltj0j
10 Sep 19
Regulation FD Disclosure
8:00am
8-K
EX-99.1
o6q6y
12 Aug 19
VBI Vaccines Announces Second Quarter 2019 Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
lrurwoqv k3
29 Jul 19
VBI Vaccines Announces Dosing of First Recurrent GBM Patient in Part B of Ongoing Phase 1/2a Study of VBI-1901
9:32am
8-K
EX-99.3
aq8q5
17 Jun 19
Regulation FD Disclosure
7:59am
8-K
EX-99.1
ftbfy966q 8u1
4 Jun 19
VBI Vaccines Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients at ASCO 2019
2:25pm
8-K
EX-99.1
dmr8e1
1 May 19
VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update
12:33pm
8-K
EX-99.1
2q1wbc78f
24 Apr 19
VBI Vaccines Provides Update on GBM Program and Announces Upcoming Conference Call
2:25pm
8-K
EX-99.1
5h4acgidlkksnatwib
9 Apr 19
VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019
3:16pm
8-K
EX-99.1
dsc85w8rrwwo9amovx2j
3 Apr 19
VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV
4:30pm
8-K
EX-99.1
8codslsxk297nfv3 6f7
25 Feb 19
VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
5:25pm